The BIONYX randomized trial is the first study to evaluate the Resolute Onyx durable polymer‐coated zotarolimus‐eluting stent (ZES) in all‐comers. Furthermore, it is the first trial to assess safety and… Click to show full abstract
The BIONYX randomized trial is the first study to evaluate the Resolute Onyx durable polymer‐coated zotarolimus‐eluting stent (ZES) in all‐comers. Furthermore, it is the first trial to assess safety and efficacy of this stent versus the Orsiro biodegradable‐polymer sirolimus‐eluting stent (SES) in all‐comers, paying particular attention to patients with diabetes. It has previously shown promising results until 3 years of follow‐up.
Keywords:
stent versus;
zotarolimus eluting;
eluting stent;
sirolimus eluting;
strut
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!